Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,780 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

NCT07203001

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations
  • Cincinnati Childrens Hospital Cincinnati, Ohio, United States
  • Legacy Emanuel Research Hosp Portland Portland, Oregon, United States
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Montreal, Quebec, Canada
View all 23 locations
View Trial Details
Recruiting

Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)

NCT07038473

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01 Jeddah, Mecca Region, Saudi Arabia
  • Sheikh Shakhbout Medical City - Site Number: 06 Abu Dhabi, United Arab Emirates
  • Dasman Diabetes Institute - Site Number: 08 Kuwait City, Al Asimah / Capital Governorate, Kuwait
  • Imam Abdulrahman Bin Faisal University - Site Number: 05 Dammam, Eastern Province, Saudi Arabia
View Trial Details
Recruiting

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

NCT06106945

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
View all 43 locations
View Trial Details
Recruiting

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

NCT05977673

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia Alessandria, IT, Italy
  • Divisione di Oncologia e dei Tumori immuto-correlati, Centro Di Riferimento Oncologico Di Aviano Aviano, Italy
  • Istituto di Ematologia L. e A. Seràgnoli, AOU Policlinico S. Orsola-Malpighi Bologna, Italy
  • SC Ematologia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia Brescia, Italy
View Trial Details
Recruiting

Study on Plasmablastic Lymphoma Patients

NCT06781359

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • IRCCS Centro di Riferimento Oncologico di Aviano, Divisione di Oncologia e dei Tumori immuno-correlati Aviano, PN, Italy
  • Ospedale C.e G. Mazzoni, U.O.C. di Ematologia Ascoli Piceno, Italy
  • ASST Spedali Civili di Brescia, Ematologia Brescia, Italy
  • A.O. S. Croce e Carle, S.C. di Ematologia e Trapianto di Midollo Osseo Cuneo, Italy
View all 23 locations
View Trial Details
Recruiting

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

NCT07630545

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more
Locations
  • The Royal Adelaide Hospital Adelaide, Australia
  • Doherty Clinical Trials Melbourne, Australia
  • Monash Health, Kingston Centre Melbourne, Australia
  • Centre Hospitalier Universitaire de Lille, Institut Cœur Poumon Lille, France
View all 18 locations
View Trial Details
Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

NCT07221500

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Institute Denver, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 37 locations
View Trial Details

Related conditions